PTGS2 and diabetes mellitus: Network pharmacology revealed 36 diabetes-related targets, with nine core targets (PPARA, FXR, PTGS2, FABP1, HMGCR, ESRRA, CYP19A1, NR3C1, G6PD) implicated in nuclear receptor signaling, lipid metabolism, and inflammatory pathways.